Pharvaris (PHVS) Cash from Investing Activities Growth (3y) (2023 - 2026)
Pharvaris (PHVS) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | -43.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.98% |
| Dec 31, 2025 | 57.97% |
| Sep 30, 2025 | 24.75% |
| Jun 30, 2025 | 40.19% |
| Mar 31, 2025 | -78.86% |
| Dec 31, 2024 | -29.92% |
| Sep 30, 2024 | -116.94% |
| Jun 30, 2024 | -15.18% |
| Mar 31, 2024 | -40.06% |
| Dec 31, 2023 | -51.81% |
| Sep 30, 2023 | 14,205.04% |
| Jun 30, 2023 | -23,372.05% |
| Mar 31, 2023 | -9.00% |